Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
Norihiro Nishimoto, Nobuyuki Miyasaka, Kazuhiko Yamamoto, Shinichi Kawai, Tsutomu Takeuchi, Junichi Azuma, Tadamitsu KishimotoVolume:
19
Language:
english
Pages:
8
DOI:
10.1007/s10165-008-0125-1
Date:
February, 2009
File:
PDF, 250 KB
english, 2009